Cardlytics, Inc.

CDLX Nasdaq CIK: 0001666071

Company Information

Industry Services-Computer Programming, Data Processing, Etc.
SIC Code 7370
Entity Type operating
SEC Category Accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 675 PONCE DE LEON AVENUE, NE, ATLANTA, GA, 30308
Mailing Address 675 PONCE DE LEON AVENUE, NE, ATLANTA, GA, 30308
Phone 888-798-5802
Fiscal Year End 1231
EIN 263039436

Financial Overview

FY2024 FY

$298.54M
Revenue
$121.91M
Cash & Equivalents

Recent SEC Filings

Form Type Date Filed Document
8-K Current report of material events January 26, 2026 View on SEC
4 Insider stock transaction report January 16, 2026 View on SEC
3 Initial insider ownership report January 16, 2026 View on SEC
4 Insider stock transaction report January 5, 2026 View on SEC
4 Insider stock transaction report January 5, 2026 View on SEC
4 Insider stock transaction report January 5, 2026 View on SEC
8-K Current report of material events December 18, 2025 View on SEC
8-K Current report of material events December 5, 2025 View on SEC
10-Q Quarterly financial report November 5, 2025 View on SEC
8-K Current report of material events November 5, 2025 View on SEC

Material Events

8-K Strategy Change January 26, 2026
High Impact
  • Cardlytics is divesting its Bridg unit to focus entirely on its core Cardlytics Engage platform, which is its primary growth engine and competitive differentiator.
  • This strategic move aims to streamline operations, eliminate complexities, and potentially improve operational efficiency and enhance overall profitability.
View Analysis

Insider Trading

SELL 3 insiders 3 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 7370)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.